Stage III (Unresectable) or Stage IV Advanced Melanoma Clinical Trial
— Checkmate 168Official title:
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti CTLA-4 Monoclonal Antibody (Checkmate 168: CHECKpoint Pathway for nivoluMAb Clinical Trial Evaluation 168)
The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.
Status | No longer available |
Enrollment | 0 |
Est. completion date | May 2018 |
Est. primary completion date | May 2018 |
Accepts healthy volunteers | |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com Inclusion Criteria: - ECOG Performance Status of 0-1 - Histologically confirmed malignant melanoma - Progressed on or after treatment with an anti-CTLA4 Exclusion Criteria: - Active brain metastases - Life Expectancy <6 weeks - Subjects who received prior therapy targeting T-cell costimulation or checkpoint pathways except for Anti CTLA-4 therapy - Subjects with autoimmune disease |
N/A
Country | Name | City | State |
---|---|---|---|
Argentina | Local Institution | Buenos Aires | |
Argentina | Local Institution | Buenos Aires | |
Argentina | Local Institution | Caba | |
Argentina | Local Institution | Capital Federal | Buenos Aires |
Argentina | Local Institution | Ciudad Autonoma De Buenos Aire | Buenos Aires |
Argentina | Local Institution | Cordoba | |
Argentina | Local Institution | Rosario | Santa Fe |
Argentina | Local Institution | San Miguel De Tucuman | Tucuman |
Argentina | Local Institution | San Miguel De Tucuman | Tucuman |
Brazil | Local Institution | Barretos | Sao Paulo |
Brazil | Local Institution | Belo Horizonte | Minas Gerais |
Brazil | Local Institution | Belo Horizonte | Minas Gerais |
Brazil | Local Institution | Brasilia | Distrito Federal |
Brazil | Local Institution | Florianopolis | Santa Catarina |
Brazil | Local Institution | Fortaleza | Ceara |
Brazil | Local Institution | Ijui | Rio Grande do Sul |
Brazil | Local Institution | Itajai | Santa Catarina |
Brazil | Local Institution | Jau | Sao Paulo |
Brazil | Local Institution | Jd. Petropolis-Londrina | Parana |
Brazil | Local Institution | Passo Fundo | Rio Grande do Sul |
Brazil | Local Institution | Porto Alegre | Rio Grande Do Sul |
Brazil | Local Institution | Ribeirao Preto | Sao Paulo |
Brazil | Local Institution | Salvador | Bahia |
Brazil | Local Institution | Santo Andre | Sao Paulo |
Brazil | Local Institution | Sao Jose do Rio Preto | Sao Paulo |
Brazil | Local Institution | Sao Paulo | |
Brazil | Local Institution | Sao Paulo | |
Brazil | Local Institution | Sao Paulo | |
Brazil | Local Institution | Sao Paulo | |
Brazil | Local Institution | Sao Paulo | |
Brazil | Local Institution | Sao Paulo | |
Canada | Local Institution | Calgary | Alberta |
Canada | Local Institution | Edmonton | Alberta |
Canada | Local Institution | Halifax | Nova Scotia |
Canada | Local Institution | Hamilton | Ontario |
Canada | Local Institution | Kelowna | British Columbia |
Canada | Local Institution | London | Ontario |
Canada | Local Institution | Moncton | New Brunswick |
Canada | Local Institution | Montreal | Quebec |
Canada | Local Institution | North Vancouver | British Columbia |
Canada | Local Institution | Ottawa | Ontario |
Canada | Local Institution | Quebec | |
Canada | Local Institution | Saskatoon | Saskatchewan |
Canada | Local Institution | St. John's | Newfoundland and Labrador |
Canada | Local Institution | Toronto | Ontario |
Canada | Local Institution | Toronto | Ontario |
Canada | Local Institution | Vancouver | British Columbia |
Canada | Local Institution | Winnipeg | Manitoba |
Colombia | Local Institution | Bogota | |
Colombia | Local Institution | Bogota | |
Colombia | Local Institution | Cali | |
Colombia | Local Institution | Medellin | |
Colombia | Local Institution | Medellin | |
Peru | Local Institution | Lima | |
Peru | Local Institution | Lima | |
Peru | Local Institution | Lima | |
United States | Lehigh Valley Health Network | Allentown | Pennsylvania |
United States | Winship Cancer Institute | Atlanta | Georgia |
United States | St. Luke'S Hospital | Bethlehem | Pennsylvania |
United States | Lynn Cancer Institute At Boca Raton Regional Hospital | Boca Raton | Florida |
United States | Mid Ohio Oncology/Hematology, Inc,Dba | Columbus | Ohio |
United States | North Shore Hematology/Oncology Associates, P.C. | East Setauket | New York |
United States | Local Institution | Encinitas | California |
United States | The Jones Clinic, Pc | Germantown | Tennessee |
United States | Cancer Specialists Of North Florida | Jacksonville | Florida |
United States | Comprehensive Cancer Centers Of Nevada | Las Vegas | Nevada |
United States | Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Lutherville | Maryland |
United States | Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida |
United States | Local Institution | Mobile | Alabama |
United States | Southern Cancer Center Pc | Mobile | Alabama |
United States | Tennessee Oncology, PLLC | Nashville | Tennessee |
United States | Icahn School Of Medicine At Mount Sinai | New York | New York |
United States | Oncology Hematology Associates Of Sw In | Newburgh | Indiana |
United States | Nebraska Cancer Specialists | Omaha | Nebraska |
United States | Florida Hospital | Orlando | Florida |
United States | Oncology Specialists, S.C. | Park Ridge | Illinois |
United States | Summit Cancer Care | Savannah | Georgia |
United States | Local Institution | Washington | District of Columbia |
United States | Waukesha Memorial Hospital | Waukesha | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
Bristol-Myers Squibb |
United States, Argentina, Brazil, Canada, Colombia, Peru,